Cingulate

Total Funding 

$7.6M

Cingulate Therapeutics uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.

Their unique combination of cutting-edge delivery technology and proven medications will create an unmatched release profile - allowing for rapid onset of action, reliable duration lasting the entire active day, and a favorable tolerability profile - all within a once-daily, oral dose for superior patient efficacy, safety, and convenience.

Number of employees

10 - 20

Headquarters

Kansas City, KS, US